SBC Medical Group Holdings Inc (SBC) EBIT Margin (2023 - 2026)
SBC Medical Group Holdings' (SBC) quarterly EBIT Margin came in at 32.47% in Q4 2025, up 2185.0% YoY from 1.42% in Q4 2024, and down 11.35% on a QoQ basis from 36.63% in Q3 2025.
SBC Medical Group Holdings Inc (SBC) EBIT Margin (2023 - 2026) Analysis & Trends
SBC Medical Group Holdings (SBC) has 3 years of EBIT Margin data on file, last reported at 32.47% in Q4 2025.
- Quarterly EBIT Margin rose 2185.0% year-over-year to 32.47% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 38.87% (up 465.0% YoY) and the FY2025 annual result came in at 38.87%, up 465.0% from the prior year.
- EBIT Margin fell to 32.47% in Q4 2025, from 36.63% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 51.39% in Q2 2024 to a low of 10.62% in Q4 2024.
- A 3-year average of 36.73% and a median of 37.55% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2024 — EBIT Margin sank 2785 bps — and 2025, when it jumped 2185 bps.
- Tracing SBC's EBIT Margin over 3 years: stood at 38.48% in 2023, then plunged by 72 bps to 10.62% in 2024, then jumped by 206 bps to 32.47% in 2025.
- The last three EBIT Margin figures came in at 32.47% (Q4 2025), 36.63% (Q3 2025), and 33.57% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.55% |
| Dec 31, 2025 | 32.47% |
| Sep 30, 2025 | 36.63% |
| Jun 30, 2025 | 33.57% |
| Mar 31, 2025 | 51.14% |
| Dec 31, 2024 | 10.62% |
| Sep 30, 2024 | 26.06% |
| Jun 30, 2024 | 51.39% |
| Mar 31, 2024 | 44.63% |
| Dec 31, 2023 | 38.48% |
| Sep 30, 2023 | 42.35% |